BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7867240)

  • 1. Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients.
    Chrysant SG; Miller E
    Clin Cardiol; 1994 Dec; 17(12):670-4. PubMed ID: 7867240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol.
    Luurila OJ; Gröhn P; Heikkilä J; Hämäläinen L; Härkönen R; Idänpään-Heikkilä U; Kohvakka A; Rytkönen U; Setälä M; Sundberg S
    Am J Cardiol; 1987 Oct; 60(10):832-5. PubMed ID: 3310576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of atenolol and diltiazem-SR on quality of life in the hypertensive patients].
    Yao XY; Fan WH; Chen JZ; Zhu JH; Chen BX; Liu XJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 32(3):231-4. PubMed ID: 12881870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
    Myburgh DP; Gordon NF
    Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained antihypertensive activity of diltiazem SR: double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring.
    Whelton A; Eff J; Magner DJ
    J Clin Pharmacol; 1992 Sep; 32(9):808-15. PubMed ID: 1430300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
    Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
    Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
    Weir MR; Fagan T; Chrysant S; Flamenbaum W; Kaihlanen PM; Lueg M; Anzalone D
    J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women.
    Applegate WB; Phillips HL; Schnaper H; Shepherd AM; Schocken D; Luhr JC; Koch GG; Park GD
    Arch Intern Med; 1991 Sep; 151(9):1817-23. PubMed ID: 1888248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy.
    Tonkin AL; Wing LM; Russell AE; West MJ; Bune AJ; Morris MJ; Cain MD; Chalmers J
    J Hypertens; 1990 Nov; 8(11):1015-9. PubMed ID: 1963183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
    Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
    J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
    Lacourcière Y; Lefebvre J; Provencher P; Poirier L
    Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical study.
    Neutel JM; Smith DH; Frishman WH
    Clin Ther; 1997; 19(6):1379-93. PubMed ID: 9444447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
    Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
    Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary response during exercise of a beta 1-selective beta-blocker (atenolol) and a calcium-channel blocker (diltiazem) in untrained subjects with hypertension.
    Cohen-Solal A; Baleynaud S; Laperche T; Sebag C; Gourgon R
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):33-8. PubMed ID: 7690093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
    Denardo SJ; Gong Y; Cooper-DeHoff RM; Farsang C; Keltai M; Szirmai L; Messerli FH; Bavry AA; Handberg EM; Mancia G; Pepine CJ
    PLoS One; 2015; 10(4):e0122726. PubMed ID: 25835002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.
    Dupont AG; Coupez JM; Jensen P; Coupez-Lopinot R; Schoors DF; Hermanns P; Nicolas M
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):701-7. PubMed ID: 1888693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.
    Neutel JM; Smith DH; Ram CV; Kaplan NM; Papademetriou V; Fagan TC; Lefkowitz MP; Kazempour MK; Weber MA
    Am J Med; 1993 Feb; 94(2):181-7. PubMed ID: 8430713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.